X4 Pharmaceuticals, Inc. (XFOR)

NASDAQ: XFOR · Real-Time Price · USD

4.040

-0.270 (-6.26%)

At close: Mar 27, 2026, 4:00 PM EDT

4.000

-0.040 (-0.99%)

After-hours: Mar 27, 2026, 4:37 PM EDT

X4 Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	217.05	55.7	99.22	121.72	81.79
Short-Term Investments	35.95	46.36	15	-	-
Cash & Short-Term Investments	253	102.06	114.22	121.72	81.79
Cash Growth	147.89%	-10.64%	-6.16%	48.82%	3.91%
Accounts Receivable	0.57	1.07	-	-	-
Other Receivables	-	0.64	0.56	1.15	0.75
Total Trade Receivables	0.57	1.71	0.56	1.15	0.75
Inventory	4.48	2.82	-	-	-
Other Current Assets	3.53	5.59	7.3	5.81	5.34
Total Current Assets	261.58	112.18	122.08	128.68	87.88
Net Property, Plant & Equipment	1.59	4.84	6.4	8.33	10.22
Other Intangible Assets	9.25	10	-	-	-
Goodwill	17.35	17.35	17.35	17.35	17.35
Other Long-Term Assets	0.69	2.08	1.44	1.23	1.72
Total Assets	290.46	146.45	147.26	155.59	117.18
Accounts Payable	5.7	8.62	8.95	7.78	4.28
Accrued Expenses	18.6	23.01	12.82	12.03	7.87
Current Portion of Long-Term Debt	-	-	-	1.32	0.8
Current Portion of Leases	0.99	1.25	1.1	1.2	1.08
Unearned Revenue	0.46	-	-	-	-
Total Current Liabilities	25.76	32.88	22.86	22.32	14.02
Long-Term Debt	76.29	75.43	54.57	32.3	33.14
Long-Term Leases	-	1.41	2.61	3.6	4.78
Other Long-Term Liabilities	2.12	14.59	16.12	23.3	0.83
Total Long-Term Liabilities	78.41	91.42	73.3	59.21	38.74
Total Liabilities	104.17	124.3	96.16	81.54	52.76
Common Stock	0.09	0.01	0.17	0	0.03
Additional Paid-in Capital	780.86	537.62	528.96	450.79	347.37
Accumulated Other Comprehensive Income	-0.11	-0.12	-0.12	-0.12	-0.12
Retained Earnings	-594.55	-515.36	-477.91	-376.74	-282.87
Shareholders' Equity	186.29	22.15	51.1	73.93	64.41
Total Liabilities & Equity	290.46	146.45	147.26	155.59	117.18
Total Debt	77.29	78.09	58.28	38.42	39.79
Net Cash (Debt)	175.71	23.97	55.94	83.3	42
Net Cash Growth	632.93%	-57.14%	-32.85%	98.32%	4.33%
Net Cash Per Share	4.16	3.58	9.44	39.34	48.94
Book Value	186.29	22.15	51.1	73.93	64.41
Book Value Per Share	4.40	3.30	8.62	34.91	75.05
Tangible Book Value	159.69	-5.2	33.75	56.58	47.06
Tangible Book Value Per Share	3.78	-0.78	5.69	26.72	54.83

Updated Mar 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q